Product Information

OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.6950 per EA under NDC 69238126401. Its NADAC has been published 473 times since Aug 2, 2017.

FDA first approved this application on May 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR PHOS 30 MG CAPSULE

Oseltamivir
$0.6950per EA

Strength

30 mg/1

NDC

69238126401

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA209093

FDA Approved

5/17/2017

TE Code

AB

On Market Since

5/21/2017

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 473 times since Aug 2, 2017, and over the history we have for it it has declined 91.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6950 per EA
All-time high$8.5683 (Jan 10, 2018)
All-time low$0.6013 (Aug 20, 2025)
52-week high$0.8323
52-week low$0.6013
Median price$1.9354
Average price$3.0945
Largest weekly change+62.9% (Jan 25, 2023)
Weeks tracked473
Tracking sinceAug 2, 2017

Price History

1W

+2.1%

1M

+2.1%

3M

-8.0%

6M

-16.2%

1Y

+15.6%

3Y

-41.9%

5Y

-75.2%

All

-91.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $0.6950 per EA (NDC 69238126401), effective Aug 19, 2026.

How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 91.7%. It has been tracked across 473 weekly CMS publications since Aug 2, 2017.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?

Since Aug 2, 2017, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.5683 (Jan 10, 2018), with a median of $1.9354 per EA.

Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?

OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 69238126401) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.